
Global Health (MEDANTA) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
10.3B
Gross Profit
7.9B
76.81%
Operating Income
1.8B
17.64%
Net Income
1.6B
15.42%
EPS (Diluted)
₹5.91
Balance Sheet Metrics
Total Assets
47.7B
Total Liabilities
13.8B
Shareholders Equity
33.9B
Debt to Equity
0.41
Cash Flow Metrics
Operating Cash Flow
1.4B
Free Cash Flow
828.7M
Revenue & Profitability Trend
Global Health Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 36.9B | 32.4B | 26.8B | 21.7B | 14.3B |
Cost of Goods Sold | 8.8B | 7.6B | 6.3B | 5.4B | 3.5B |
Gross Profit | 28.1B | 24.8B | 20.6B | 16.2B | 10.8B |
Gross Margin % | 76.2% | 76.6% | 76.7% | 74.9% | 75.6% |
Operating Expenses | |||||
Research & Development | - | 420.0K | 340.0K | 590.0K | 270.0K |
Selling, General & Administrative | 5.0B | 5.3B | 4.2B | 2.4B | 294.6M |
Other Operating Expenses | 6.1B | 3.5B | 3.1B | 3.7B | 3.5B |
Total Operating Expenses | 11.1B | 8.8B | 7.3B | 6.0B | 3.8B |
Operating Income | 6.8B | 6.7B | 5.0B | 3.2B | 927.0M |
Operating Margin % | 18.5% | 20.6% | 18.6% | 15.0% | 6.5% |
Non-Operating Items | |||||
Interest Income | - | 596.8M | 355.4M | 167.2M | 177.6M |
Interest Expense | 652.6M | 725.4M | 774.6M | 794.9M | 671.0M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 6.5B | 6.3B | 4.5B | 2.8B | 324.6M |
Income Tax | 1.7B | 1.5B | 1.2B | 843.6M | 36.6M |
Effective Tax Rate % | 25.6% | 23.8% | 27.4% | 30.1% | 11.3% |
Net Income | 4.8B | 4.8B | 3.3B | 2.0B | 288.0M |
Net Margin % | 13.0% | 14.8% | 12.2% | 9.1% | 2.0% |
Key Metrics | |||||
EBITDA | 9.6B | 9.0B | 6.8B | 4.9B | 2.3B |
EPS (Basic) | ₹17.92 | ₹17.80 | ₹12.58 | ₹7.75 | ₹1.15 |
EPS (Diluted) | ₹17.92 | ₹17.80 | ₹12.57 | ₹7.73 | ₹1.14 |
Basic Shares Outstanding | 268659040 | 268607382 | 259208847 | 253236430 | 251408994 |
Diluted Shares Outstanding | 268659040 | 268607382 | 259208847 | 253236430 | 251408994 |
Income Statement Trend
Global Health Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 2.3B | 4.2B | 7.7B | 1.2B | 694.7M |
Short-term Investments | 9.2B | 7.3B | 4.9B | 3.9B | 2.2B |
Accounts Receivable | 2.9B | 2.2B | 1.9B | 1.8B | 1.3B |
Inventory | 671.4M | 668.5M | 603.7M | 533.9M | 397.6M |
Other Current Assets | 189.9M | 168.6M | 141.3M | 41.5M | - |
Total Current Assets | 15.3B | 15.1B | 15.8B | 8.1B | 5.0B |
Non-Current Assets | |||||
Property, Plant & Equipment | 25.1B | 13.1B | 11.3B | 9.9B | 8.1B |
Goodwill | 112.8M | 55.4M | 51.7M | 62.7M | 72.4M |
Intangible Assets | 112.8M | 55.4M | 51.7M | 62.7M | 72.4M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 512.6M | 173.1M | 10.0K | - | - |
Total Non-Current Assets | 32.3B | 28.0B | 25.4B | 23.3B | 21.9B |
Total Assets | 47.7B | 43.0B | 41.2B | 31.5B | 26.9B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 1.9B | 1.9B | 1.9B | 1.3B | 1.3B |
Short-term Debt | 942.3M | 1.7B | 1.4B | 1.1B | 1.0B |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 1.5B | 28.6M | 189.9M | 23.7M | 14.1M |
Total Current Liabilities | 6.2B | 6.2B | 5.7B | 4.2B | 4.0B |
Non-Current Liabilities | |||||
Long-term Debt | 6.2B | 6.3B | 9.8B | 10.0B | 8.3B |
Deferred Tax Liabilities | 0 | 241.6M | 188.1M | 0 | 0 |
Other Non-Current Liabilities | 221.2M | 480.0K | 468.4M | - | - |
Total Non-Current Liabilities | 7.6B | 7.8B | 11.2B | 11.1B | 9.1B |
Total Liabilities | 13.8B | 14.0B | 16.9B | 15.3B | 13.1B |
Equity | |||||
Common Stock | 537.2M | 537.0M | 536.4M | 506.4M | 495.9M |
Retained Earnings | - | 17.6B | 12.8B | 9.5B | 7.7B |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 33.9B | 29.1B | 24.3B | 16.2B | 13.8B |
Key Metrics | |||||
Total Debt | 7.2B | 8.0B | 11.2B | 11.1B | 9.3B |
Working Capital | 9.1B | 8.9B | 10.1B | 3.9B | 974.7M |
Balance Sheet Composition
Global Health Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 6.5B | 6.3B | 4.5B | 2.8B | 324.6M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | 0 | 1.6M | 7.5M | 17.4M | 37.9M |
Working Capital Changes | -1.3B | -549.0M | 424.6M | -518.7M | 357.8M |
Operating Cash Flow | 5.4B | 5.7B | 5.2B | 2.8B | 1.0B |
Investing Activities | |||||
Capital Expenditures | -5.1B | -2.8B | -2.4B | -2.7B | -1.4B |
Acquisitions | - | - | - | - | - |
Investment Purchases | -1.4B | - | -1.4B | -1.7B | -1.2B |
Investment Sales | - | - | - | 83.7M | 50.4M |
Investing Cash Flow | -6.6B | -5.2B | -5.0B | -4.4B | -2.5B |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | 1.5B | 1.4B | 390.8M | 2.4B | 0 |
Debt Repayment | -1.8B | -5.8B | -666.5M | -198.9M | -30.2M |
Financing Cash Flow | -330.0M | -4.5B | 4.5B | 2.5B | -28.6M |
Free Cash Flow | -241.6M | 3.3B | 4.1B | 367.9M | 960.3M |
Net Change in Cash | -1.5B | -3.9B | 4.7B | 992.6M | -1.5B |
Cash Flow Trend
Global Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
69.59
Forward P/E
59.22
Price to Book
11.01
Price to Sales
10.09
PEG Ratio
59.22
Profitability Ratios
Profit Margin
13.04%
Operating Margin
18.84%
Return on Equity
15.30%
Return on Assets
9.42%
Financial Health
Current Ratio
2.48
Debt to Equity
21.19
Beta
-0.32
Per Share Data
EPS (TTM)
₹19.92
Book Value per Share
₹125.91
Revenue per Share
₹137.44
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
medanta | 372.6B | 69.59 | 11.01 | 15.30% | 13.04% | 21.19 |
Max Healthcare | 1.2T | 115.26 | 13.09 | 12.10% | 15.31% | 32.09 |
Apollo Hospitals | 1.1T | 75.97 | 13.42 | 18.85% | 6.63% | 90.89 |
Fortis Healthcare | 677.5B | 78.10 | 7.60 | 8.44% | 10.73% | 26.99 |
Narayana Hrudayalaya | 358.6B | 45.78 | 9.89 | 21.78% | 13.82% | 66.93 |
Aster DM Healthcare | 313.7B | 95.60 | 8.80 | 147.28% | 7.55% | 55.26 |
Financial data is updated regularly. All figures are in the company's reporting currency.